Source: The Business Journals: Columbus Business First

CoverMyMeds: Another unicorn, new startup from CoverMyMeds founder among top VC deals in 2022

A new unicorn, a biotech manufacturer, ticketing software and the next startup from CoverMyMeds co-founder Matt Scantland led Central Ohio's top venture capital rounds of 2022 - and while the region's total was less than half that of the record-smashing 2021, it was still higher than any prior year. Publicly disclosed funding rounds for Central Ohio technology companies totaled $617 million, according to Columbus Business First research. Regulatory filings for rounds not yet closed could add about...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Matt Scantland's photo - Co-Founder & CEO of CoverMyMeds

Co-Founder & CEO

Matt Scantland

CEO Approval Rating

74/100

Read more